Entering text into the input field will update the search result below

How to reinvest dividends? A new approach to the "Dogs of Dow" strategy

May 01, 2011 7:19 PM ETMCD, T3 Comments
Nojus profile picture
Nojus's Blog
Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.
We have decided to upgrade one of the DOW dividend Investment Strategy. We hope this improvement will help to achieve better return on investments. We have chosen to “improve” strategy “Dogs of the Dow”.
The basis of our new portfolio “Portfolio #12 -DDD” is “Portfolio #1 - Dogs of the Dow”.

Everyone knows that the dividends must be reinvested back. Usually we have reinvest dividends into stocks of the same company.

Is there a better way to reinvest dividends? We think so.

We have decided to reinvest dividends into companies with the best rates of profitability in this portfolio. We have chosen only one criterion – profitability of the retained earnings.

Estimation is very easy: all net profit minus all dividends during 10 years. Second step: (EPS’10-EPS’01)/(net profit minus all dividends during 10 years). The companies with the biggest profitability are our stocks for reinvesting.

AT&T Inc – 27.91%;
McDonald's Corporation – 24.49%;
Chevron Corp – 15.09%.

So, we will divide every dollar of dividends into the three parts and will reinvest dividends into the stocks of TMCD and CVX.
We launched portfolio #12 –DDD on April 21          
Portfolio #12 –DDD – 2.16%.

DJIA – 2.44%
SP500 – 1.96%.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Recommended For You

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.